Frequently Asked Questions
The market is segmented based on , By Treatment (Pre-Eclampsia/Eclampsia, Postpartum Haemorrhage, Others), Product Type (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Haemorrhage, Labor Induction, and Labor Arrest), Source of Origin (Synthetic Oxytocin, Natural Oxytocin (Animal Pituitary Extract), End User (Hospitals, Specialty Clinics, Diagnostic Centers and Others) – Industry Trends and Forecast to 2030.
.
The Global Oxytocic Pharmaceutical Market size was valued at USD 106.69 USD Million in 2022.
The Global Oxytocic Pharmaceutical Market is projected to grow at a CAGR of 8.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Fresenius Kabi AG, Biofutura, Abbott, JHP Pharmaceuticals, Baxter, Pfizer , Ferring B.V., Novartis AG, Teva Pharmaceutical Industries Ltd
-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
